CURRENT Essentials of Critical Care.pdf

Oxygen therapy, 87, 93for hypervolemia, 63in inhalation injury, 82pulse oximetry during, 20Oxygen toxicity, on mechanical ventilation, 101Oxyhemoglobin, 247PPacemaker, 122, 128, 195, 228Pacing, for supraventricular tachycardia, 127Pain, 18, 174, 192, 225, 249, 256, 285. See alsoAbdominal pain; Chest painanxiety associated with, 3in arterial insufficiency, 118axial skeletal, 280in pancreatitis, 173in renal disorders, 211in SAH, 203in sickle cell disease, 81Pain control, 32for AMI, 126in arterial insufficiency, 118in pancreatic insufficiency, 172for pancreatitis, 173Pallor, 128, 279Palpitations, 119, 120, 127, 130, 183Pancreatic insufficiency, 172Pancreatitis, 173ARDS associated with, 93chronic, 172in transplant recipients, 28Pancytopenia, in leukemia, 279Pantoprazole, 21Papaverine, 124Papilledema, 68, 193, 194, 203Paracentesis, 63, 163Paralysis, 192, 238, 248, 255in arterial insufficiency, 118in hypokalemia, 56Paranoia, 241Paraproteinemia, pathological, 65Parathyroidectomy, hypocalcemia following, 54Paresthesias, 66, 69, 192in electrolyte imbalances, 54, 56perioral, 255Paroxysmal nocturnal dyspnea, 125Partial thromboplastin times, dermatologydisorders associated with, 261Pelvic pain, in septic abortion, 291Pemphigus vulgaris, 269Penicillins, 156, 158, 249, 252, 266Pentamidine, 151Peptic ulcer disease (PUD), 174Perceptions, altered, 252. See also Mental status,alteredPercutaneous coronary intervention (PCI), 129Pericardial catheter, 74Pericardial effusion, 120Pericardial rub, 120, 213Pericardial window, 120Pericardiocentesis, 74, 120Pericarditis, 26, 208Periodontal infection, 95Peripheral parenteral nutrition (PPN), 15Peritonitis, 150Perspiration, 128, 237. See also diaphoresisPetechiae, 45, 49, 271, 279Peutz-Jeghers syndrome, 176pH, in acid-base disorders, 65, 66, 67, 68, 69Pharyngitis, 157, 270, 274Phencyclidine (PCP), 233Phenobarbital, 230, 241, 242Phenothiazines, 241Phentolamine, 123, 241Phenylephrine, 77, 243Phenytoin, 203, 230, 231, 233, 241Phenytoin hypersensitivity syndrome, 270Phosphate, 181, 182in electrolyte imbalances, 61, 62in renal insufficiency, 62Phosphate-binders, 61Phosphorus replacement, 62Photochemotherapy, 265Photophobia, 203, 272Piloerection, in opioid withdrawal, 237Pituitary adenoma, 180Plaques, 262, 265Plasma exchange, 192, 196in gastritis, 168for vasculitis, 222Plasmapheresis, 219, 221for pemphigus vulgaris, 269in renal disorders, 208, 212Plasma transfusions, 43Platelet dysfunction, 39, 44, 250Platelet glycoprotein IIb/IIIa antagonists, 129Platelet inhibitors, bleeding associated with, 39Platelet transfusion, 76Pleocytosis, CSF, 198Pleural effusions, 88in hypervolemia, 63respiratory failure associated with, 107thoracostomy for, 85Pleuritic chest pain, 90, 120in HIV-infected patients, 153pleural effusions associated with, 88in pneumonia, 136Pneumocystis jiroveci pneumonia (PCP), 151,153Pneumomediastinum, 97, 101, 230Pneumonia, 99, 149, 152, 220ARDS associated with, 93aspiration, 95community-acquired, 137end-tidal PCO 2 in, 10hematogenous, 149in HIV-infected patients, 153nosocomial, 149pneumocystis, 151, 153ventilator-associated, 99, 101, 111, 152Pneumonitis, aspiration, 95Pneumothorax, 89on mechanical ventilation, 97, 101tension, 85thoracostomy for, 85in toxicology disorders, 230Poisoningcarbon monoxide, 247mushroom, 252organophosphate, 238salicylate, 239warfarin, 244Polydipsia, 181, 182Polyneuropathy, 106, 190, 191Polyphagia, in hyperosmolar non-ketotic diabeticcoma, 182Polypharmacy, 11Polyradiculopathy, acute inflammatorydemyelinating (AIDP), 192Polyuria, 53, 59, 181, 182Polyvalent, in snakebite, 255Pontine lesions, 202Portal hypertension, 209Positioning, 128, 220to decrease aspiration risk, 95in increased ICP, 194Positive end-expiratory pressure (PEEP), 93, 98,99, 104, 109Positive pressure ventilation, 68, 86, 101Postsplenectomy patients, infections in, 141Posttransplant lymphoproliferative disorder(PTLD), 28